Early work on the function of CD95, an interview with Shige Nagata.
Nagata
Shige
S
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D051017:Apoptosis Regulatory Proteins; D003001:Cloning, Molecular; D003851:Deoxyribonucleases / Q000266:history / Q000502:physiology; D053222:Fas Ligand Protein; D049673:History, 20th Century; D006801:Humans; D007564:Japan; D008232:Lymphoproliferative Disorders / Q000235:genetics; D008562:Membrane Glycoproteins / Q000235:genetics / Q000266:history; D009369:Neoplasms / Q000188:drug therapy; D010827:Physiology / Q000266:history*; D011506:Proteins / Q000266:history / Q000502:physiology; D019014:fas Receptor / Q000235:genetics / Q000266:history / Q000502:physiology*
D051017:Apoptosis Regulatory Proteins; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D011506:Proteins; C109664:caspase-activated DNase inhibitor; D019014:fas Receptor; D003851:Deoxyribonucleases; C109663:caspase-activated deoxyribonuclease